CBD is well tolerated in humans with doses up to 600 mg not resulting in psychotic symptoms (15). In the few small placebo-controlled studies performed, no significant CNS effects were noted. Oral CBD undergoes extensive first-pass metabolism via CYP3A4, with a bioavailability of 6%. Following single doses in humans, the half-life of CBD when taken orally is about 1 to 2 days.1 In vitro studies have shown that CBD is a potent inhibitor of multiple CYP isozymes, including CYP 2C and CYP3A (16, 17). Whether these in vitro observations are relevant at plasma concentrations likely to be seen in patients is unclear. In addition, given its metabolism via CYP3A4, clinical trials of CBD in patients receiving enzyme-inducing AEDs, such as carbamazepine or phenytoin, will require detailed pharmacokinetic studies.
 Arterial Ischemic Stroke occurs when blood flow in an artery to the brain is blocked due to narrowness of the artery or the formation of a blood clot. Neonatal (i.e. newborn) Arterial Ischemic Stroke grimly means there is a condition specific to infants. Woefully little is known about NAIS, but it can certainly lead to lifelong disabilities and/or brain injury. Currently, there is no effective treatment.
Authors: Leinwand, Kristina L. DO; Gerich, Mark E. MD; Hoffenberg, Edward J. MD; Collins, Colm B. PhD; National Institutes of Health T32 Institutional Training Grant in Pediatric Gastroenterology; National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health; Colorado Department of Public Health and Environment

Other targets for CBD include transient receptor potential (TRP) channels that are involved with the modulation of intracellular calcium (1, 6). Cannabinoids are highly lipophilic, allowing access to intracellular sites of action, resulting in increases in calcium in a variety of cell types including hippocampal neurons. CBD actions on calcium homeostasis may provide a basis for CBD neuroprotective properties.
A survey of patients seen in a tertiary epilepsy center found that 21% of patients admitted to using marijuana in the last year, and 24% of patients believed marijuana to be effective for their seizures (10). While interesting, this anecdotal observation does not rise to the level of evidence needed to evaluate a potential new therapeutic modality.

After two years of R&D and lots of testing and learning, Love CBD had already established itself as one of the pioneer brands in the UK for sprays and balms. Love CBD produces some of the strongest CBD sprays we’ve found in the UK market: the 1400mg CBD Spray and the 2000mg CBD spray (both in a 20ml bottle). The CBD oil is full spectrum, with high CBDa content to achieve the entourage effect. Love CBD also supplies an XL (100g) high-strength CBD Balm with 1000mg of CBD oil content and natural ingredients only: Cannabis Sativa L., coconut oil, shea butter, cacao, grape seed oil, rosemary, and natural vanilla aroma. Ideal for a good back rub before bed. Visit the Love CBD collection.

These reports suffered from a number of design flaws, including incomplete baseline quantification of baseline seizure frequency, indeterminate time periods for outcome determination and, in some cases, inadequate (or missing) statistical analysis—in general, a lack of sufficient detail to adequately evaluate and interpret the findings. Limitations aside, several studies did report that administration of adjunctive CBD did not result in meaningful changes in seizure frequency (11–13).

Hemp CBD is completely different from cannabis CBD. Hemp also derives from the Cannabis sativa L plant, and while it also contains THC, it contains it in volumes that are less than 0.3% by dry weight. Some governments, including the US, regulate the concentration of THC and permit a specific variety of hemp (called industrial hemp) that is bred with an especially low THC content. This is the reason why, when you type into Google “CBD oil for Sale”, you get hundreds of companies trying to sell you their products – according to most all of them, CBD oil from industrial hemp is 100% legal to sell online and ship to all 50 states.


Several weeks after a hysterectomy last spring, Bo Roth was suffering from exhaustion and pain that kept her on the couch much of the day. The 58-year-old Seattle speech coach didn’t want to take opioid pain-killers, but Tylenol wasn’t helping enough. Roth was intrigued when women in her online chat group enthused about a cannabis-derived oil called cannabidiol (CBD) that they said relieved pain without making them high. So Roth, who hadn’t smoked weed since college but lived in a state where cannabis was legal, walked into a dispensary and bought a CBD tincture.
This method proved successful for years, but high-strength concentrates would sometimes crystallise and clog the very small orifice through which the oil was to be delivered. Recognising the issue and the fact that most customers needed a higher dose to be delivered quickly, CannabiGold further developed its packaging to launch a side nozzle. This pump can deliver a higher dose of the oil (4 times what it used to) in one go and do it very easily under the tongue, without having to use a mirror to ensure one is getting the right number of drops. The easy dropper technology has boosted the good reputation of the already popular cylinder bottles because they’re easy and safe to use wherever you go with no leaking and a very convenient pocket size. Each of their 12g bottles now contains 100 pumps (full doses) of CBD, making it the easiest and most convenient system available, truly suitable for all use, including travel. Visit the CannabiGold collection.
×